More on SPRB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.9 Score)

Upcoming Events

- Earnings (11/16/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Spruce Biosciences (NQ:SPRB)
Delayed: 39.65 -1.82 (4.39%)
Prev. Close $41.47  
Open$41.53 
52 Wk High$ 
52 Wk Low$ 
Day High$41.84 
Day Low$39.21 
P/E N/A  
EPS$ 
Volume88,432 

Friends, Peers and Foes (?): SPRBD, 6XY SPRUCEBIO (more...)

Oct 15, 2026 04:05 PM Spruce Biosciences to Participate in the Craig-Hallum Biotech Catalyst Conference
Oct 8, 2026 04:05 PM Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurology Society Annual Meeting
Oct 5, 2026 05:07 AM B.Riley Reiterates Buy Rating on Spruce Biosciences, Inc. (SPRB)
Sep 24, 2026 04:19 AM Spruce Biosciences (SPRB) Reiterated at Market Outperform by Citizens on TA-ERT Therapy Lead
Sep 18, 2026 05:20 AM Spruce Biosciences (SPRB) Reiterated at Market Outperform by Citizens
Sep 17, 2026 07:46 AM Lake Street Starts Spruce Biosciences, Inc. (SPRB) at Buy
Aug 26, 2026 08:00 AM Spruce Biosciences Announces Launch of MPS3BStudy.com
Aug 26, 2026 06:43 AM H.C. Wainwright Reiterates Buy Rating on Spruce Biosciences, Inc. (SPRB)
Aug 24, 2026 08:03 AM Spruce Biosciences BLA filing for rare disease drug on track for 2026
Aug 24, 2026 08:00 AM Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
View All Articles

Entities mentioned with SPRB

View All Entities